Combination for treating cancer
AssigneeNitto Denko Corporation
InventorsHiroyuki TANAKA, Kenjiro MINOMI, Hirokazu TAKAHASHI, Yasuaki TAMURA, Norio TAKEI, Akihiro YONEDA
Life of this patent
Estimating the term…
Abstract
A combination including (1) a molecule including the nucleotide sequence of SEQ ID NO: 1 and (2) an anticancer agent; and a method for treating a cancer, including administering an effective amount of the combination to a subject in need thereof. The anticancer agent may be an inhibitor of a BcL2 family molecule. The inhibitor of a BcL2 family molecule may be an expression inhibitor of the BcL2 family molecule or a function inhibitor of the BcL2 family molecule.
Claims19
A combination comprising (1) a molecule comprising the nucleotide sequence of SEQ ID NO:
- 1 and (2) an anticancer agent.
(canceled)
(canceled)
(canceled)
A method for treating a cancer, comprising administering an effective amount of (1) a molecule comprising the nucleotide sequence of SEQ ID NO:
- 1 and (2) an anticancer agent to a subject in need thereof.
(canceled)
Dependencies are inferred from the claim text.